{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:13:05Z","timestamp":1790629985783,"version":"4.1.0"},"reference-count":273,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Alzheimer\u2019s (AD) and Parkinson\u2019s (PD) diseases are two distinct age-related pathologies that are characterized by various common dysfunctions. They are referred to as proteinopathies characterized by ubiquitinated protein accumulation and aggregation. This accumulation is mainly due to altered lysosomal and proteasomal clearing processes and is generally accompanied by ER stress disturbance, autophagic and mitophagic defects, mitochondrial structure and function alterations and enhanced neuronal cell death. Genetic approaches aimed at identifying molecular triggers responsible for familial forms of AD or PD have helped to understand the etiology of their sporadic counterparts. It appears that several proteins thought to contribute to one of these pathologies are also likely to contribute to the other. One such protein is parkin (PK). Here, we will briefly describe anatomical lesions and genetic advances linked to AD and PD as well as the main cellular processes commonly affected in these pathologies. Further, we will focus on current studies suggesting that PK could well participate in AD and thereby act as a molecular bridge between these two pathologies. In particular, we will focus on the transcription factor function of PK and its newly described transcriptional targets that are directly related to AD- and PD-linked cellular defects.<\/jats:p>","DOI":"10.3390\/biom12040559","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T05:13:08Z","timestamp":1649481188000},"page":"559","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Parkin as a Molecular Bridge Linking Alzheimer\u2019s and Parkinson\u2019s Diseases?"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2098-1750","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Checler","sequence":"first","affiliation":[{"name":"IPMC, UMR7275 CNRS-UCA, INSERM, Labex DistALZ, 660 Route des Lucioles, 06560 Valbonne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7777-005X","authenticated-orcid":false,"given":"Cristine","family":"Alves da Costa","sequence":"additional","affiliation":[{"name":"IPMC, UMR7275 CNRS-UCA, INSERM, Labex DistALZ, 660 Route des Lucioles, 06560 Valbonne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a004457","article-title":"Alzheimer\u2019s disease","volume":"3","author":"Selkoe","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","first-page":"a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Frosch","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2353\/ajpath.2009.080814","article-title":"The unfolded protein response is activated in pretangle neurons in Alzheimer\u2019s disease hippocampus","volume":"174","author":"Hoozemans","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1007\/s12035-020-01929-y","article-title":"Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer\u2019s Disease","volume":"57","author":"Uddin","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1179\/1743132814Y.0000000448","article-title":"Endoplasmic reticulum stress as a novel neuronal mediator in Alzheimer\u2019s disease","volume":"37","author":"Huang","year":"2015","journal-title":"Neurol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1111\/bph.14585","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: Role in pathogenesis and novel therapeutic opportunities","volume":"176","author":"Swerdlow","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","article-title":"Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer\u2019s disease models and human brains","volume":"141","author":"Mary","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","article-title":"Extensive involvement of autophagy in Alzheimer disease: An immuno-electron microscopy study","volume":"64","author":"Nixon","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1080\/15548627.2021.1963630","article-title":"Endolysosome and autophagy dysfunction in Alzheimer disease","volume":"17","author":"Hung","year":"2021","journal-title":"Autophagy"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1096\/fj.201700359","article-title":"Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer\u2019s disease: Inseparable partners in a multifactorial disease","volume":"31","author":"Nixon","year":"2017","journal-title":"FASEB J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s40263-019-00643-1","article-title":"Endolysosome and Autolysosome Dysfunction in Alzheimer\u2019s Disease: Where Intracellular and Extracellular Meet","volume":"33","author":"Scheper","year":"2019","journal-title":"CNS Drugs"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00401-016-1577-6","article-title":"Intraneuronal aggregation of the beta-CTF fragment of APP (C99) induces Abeta-independent lysosomal-autophagic pathology","volume":"132","author":"Lauritzen","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"592607","DOI":"10.3389\/fncel.2020.592607","article-title":"Synaptic Loss in Alzheimer\u2019s Disease: Mechanistic Insights Provided by Two-Photon in vivo Imaging of Transgenic Mouse Models","volume":"14","author":"Subramanian","year":"2020","journal-title":"Front. Cell Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13195-020-00588-4","article-title":"The clinical promise of biomarkers of synapse damage or loss in Alzheimer\u2019s disease","volume":"12","author":"Zetterberg","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3858\/emm.2010.42.5.040","article-title":"Induction of the unfolded protein response and cell death pathway in Alzheimer\u2019s disease, but not in aged Tg2576 mice","volume":"42","author":"Lee","year":"2010","journal-title":"Exp. Mol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1172\/JCI22317","article-title":"Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: Cause or effect?","volume":"114","author":"Dickson","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-2001-3208","article-title":"Apoptotic neurons in Alzheimer\u2019s disease frequently show intracellular Abeta42 labeling","volume":"3","author":"Chui","year":"2001","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pharmthera.2013.11.009","article-title":"p53 in neurodegenerative diseases and brain cancers","volume":"142","author":"Checler","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"173873","DOI":"10.1016\/j.ejphar.2021.173873","article-title":"Apoptotic neurons and amyloid-beta clearance by phagocytosis in Alzheimer\u2019s disease: Pathological mechanisms and therapeutic outlooks","volume":"895","author":"Tajbakhsh","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.2880399","article-title":"The genetic defect causing familial Alzheimer\u2019s disease maps on chromosome 21","volume":"235","author":"Tanzi","year":"1987","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-12-385883-2.00008-4","article-title":"The genetics of Alzheimer\u2019s disease","volume":"107","author":"Bertram","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng1292-330","article-title":"Genetic evidence for a novel fami!lial Alzheimer\u2019s disease locus on chromosome 14","volume":"2","author":"Haines","year":"1992","journal-title":"Nat. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","article-title":"Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene","volume":"376","author":"Rogaev","year":"1995","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.7638621","article-title":"A familial Alzheimer\u2019s disease locus on chromosome 1","volume":"269","author":"Wijsman","year":"1995","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: A genetic approach","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","article-title":"Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein","volume":"391","author":"Saftig","year":"1998","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/35017105","article-title":"Total inactivation of g-secretase activity in presenilin-deficient embryonic stem cells","volume":"2","author":"Herreman","year":"2000","journal-title":"Nat. Cell. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI8728","article-title":"The role of presenilins in Alzheimers\u2019 disease","volume":"104","author":"Thinakaran","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(00)00051-9","article-title":"Ab-generating enzymes: Recent advances in b- and g-secretases research","volume":"27","author":"Vassar","year":"2000","journal-title":"Neuron"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnagi.2016.00051","article-title":"Effect of Presenilin Mutations on APP Cleavage; Insights into the Pathogenesis of FAD","volume":"8","author":"Li","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1046\/j.1471-4159.1997.69062494.x","article-title":"\u03b1-secretase-derived product of b-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer\u2019s disease","volume":"69","author":"Ancolio","year":"1997","journal-title":"J. Neurochem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1073\/pnas.1619574114","article-title":"Presenilin-1 mutations and Alzheimer\u2019s disease","volume":"114","author":"Kelleher","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sexton, C., Snyder, H., Beher, D., Boxer, A.L., Brannelly, P., Brion, J.P., Buee, L., Cacace, A.M., Chetelat, G., and Citron, M. (2021). Current directions in tau research: Highlights from Tau 2020. Alzheimer\u2019s Dement.","DOI":"10.1002\/alz.12452"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"100489","DOI":"10.1016\/j.jbc.2021.100489","article-title":"Is gamma-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?","volume":"296","author":"Checler","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fnagi.2019.00244","article-title":"Emerging Alternative Proteinases in APP Metabolism and Alzheimer\u2019s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP","volume":"11","author":"Pilat","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00018-015-1992-1","article-title":"MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer\u2019s disease","volume":"73","author":"Baranger","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature14864","article-title":"\u03b7-Secretase processing of APP inhibits neuronal activity in the hippocampus","volume":"526","author":"Willem","year":"2015","journal-title":"Nature"},{"key":"ref_42","first-page":"159","article-title":"The Metalloprotease Meprin beta Is an Alternative beta-Secretase of APP","volume":"9","author":"Pietrzik","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"100963","DOI":"10.1016\/j.jbc.2021.100963","article-title":"Dipeptidyl peptidase 4 contributes to Alzheimer\u2019s disease-like defects in a mouse model and is increased in sporadic Alzheimer\u2019s disease brains","volume":"297","author":"Valverde","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00401-021-02308-0","article-title":"Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer\u2019s disease (AD) mouse model and is increased at early stage in sporadic AD brain","volume":"141","author":"Valverde","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1074\/jbc.R118.003999","article-title":"Are N- and C-terminally truncated Abeta species key pathological triggers in Alzheimer\u2019s disease?","volume":"293","author":"Dunys","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_46","unstructured":"Wisniewski, T. (2019). N-Terminally Truncated Abeta Peptide Variants in Alzheimer\u2019s Disease. Alzheimer\u2019s Disease, Exon Publications."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"710579","DOI":"10.3389\/fnagi.2021.710579","article-title":"N-Truncated Abeta Starting at Position Four-Biochemical Features, Preclinical Models, and Potential as Drug Target in Alzheimer\u2019s Disease","volume":"13","author":"Bayer","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1073\/pnas.0908953107","article-title":"Alzheimer\u2019s-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition","volume":"107","author":"Jiang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neurobiolaging.2018.06.038","article-title":"Intraneuronal accumulation of C99 contributes to synaptic alterations, apathy-like behavior, and spatial learning deficits in 3xTgAD and 2xTgAD mice","volume":"71","author":"Bourgeois","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.neuron.2019.11.010","article-title":"A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP beta-CTFs, Not Abeta","volume":"104","author":"Kwart","year":"2019","journal-title":"Neuron"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41467-017-02533-w","article-title":"Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures","volume":"9","author":"Miranda","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/1567205016666190325092841","article-title":"Does Intraneuronal Accumulation of Carboxyl-terminal Fragments of the Amyloid Precursor Protein Trigger Early Neurotoxicity in Alzheimer\u2019s Disease?","volume":"16","author":"Lauritzen","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2174\/1389557519666191104110908","article-title":"Parkinson\u2019s Disease: A Review from Pathophysiology to Treatment","volume":"20","author":"Marino","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/mp.2013.3","article-title":"Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson\u2019s disease","volume":"19","author":"Drui","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fncel.2016.00293","article-title":"Early Degeneration of Both Dopaminergic and Serotonergic Axons-A Common Mechanism in Parkinson\u2019s Disease","volume":"10","author":"Grosch","year":"2016","journal-title":"Front. Cell Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13024-019-0332-6","article-title":"Impaired dopamine metabolism in Parkinson\u2019s disease pathogenesis","volume":"14","author":"Masato","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1111\/febs.14607","article-title":"Determinants of dopaminergic neuron loss in Parkinson\u2019s disease","volume":"285","author":"Surmeier","year":"2018","journal-title":"FEBS J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1073\/pnas.94.8.4113","article-title":"Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments","volume":"94","author":"Spillantini","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","first-page":"1720621","article-title":"Alpha-Synuclein in Parkinson\u2019s Disease: From Pathogenetic Dysfunction to Potential Clinical Application","volume":"2016","author":"Xu","year":"2016","journal-title":"Parkinson\u2019s Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mcp.2016.11.001","article-title":"Genetics of Parkinson\u2019s disease","volume":"30","author":"Lill","year":"2016","journal-title":"Mol. Cell Probes"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Day, J.O., and Mullin, S. (2021). The Genetics of Parkinson\u2019s Disease and Implications for Clinical Practice. Genes, 12.","DOI":"10.3390\/genes12071006"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson\u2019s disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson\u2019s disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"104782","DOI":"10.1016\/j.nbd.2020.104782","article-title":"Genetics of Parkinson\u2019s disease: An introspection of its journey towards precision medicine","volume":"137","author":"Kim","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","article-title":"A gene for Parkinson\u2019s disease maps to 4q21-q23","volume":"274","author":"Polymeropoulos","year":"1996","journal-title":"Science"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1086\/302486","article-title":"Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein","volume":"65","author":"Athanassiadou","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding a-synuclein in Parkinson\u2019s disease","volume":"18","author":"Kuhn","year":"1998","journal-title":"Nat. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of a-syunuclein, causes Parkinson and Lewy bodies dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/humu.21277","article-title":"Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: A mutation update","volume":"31","author":"Nuytemans","year":"2010","journal-title":"Hum. Mutat."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddi215","article-title":"Loss of function mutations in the gene encoding Omi\/HtrA2 in Parkinson\u2019s disease","volume":"14","author":"Strauss","year":"2005","journal-title":"Hum. Mol. Gen."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","article-title":"VPS35 mutations in Parkinson disease","volume":"89","author":"Wider","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between early-onset Parkinson\u2019s disease and mutations in the Parkin gene","volume":"342","author":"Bonifati","year":"2000","journal-title":"New Eng. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/WCO.0b013e3281e6692b","article-title":"Impact of recent genetic findings in Parkinson\u2019s disease","volume":"20","author":"Klein","year":"2007","journal-title":"Curr. Opin. Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1152\/physrev.00022.2010","article-title":"What Genetics Tells us About the Causes and Mechanisms of Parkinson\u2019s Disease","volume":"91","author":"Corti","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1001\/archneur.61.12.1898","article-title":"Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease","volume":"61","author":"Rogaeva","year":"2004","journal-title":"Arch. Neurol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1212\/01.wnl.0000167546.39375.82","article-title":"Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes","volume":"65","author":"Bonifati","year":"2005","journal-title":"Neurology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10072-003-0108-0","article-title":"DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism","volume":"24","author":"Bonifati","year":"2003","journal-title":"Neurol. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"239854","DOI":"10.1155\/2013\/239854","article-title":"Endoplasmic reticulum stress and Parkinson\u2019s disease: The role of HRD1 in averting apoptosis in neurodegenerative disease","volume":"2013","author":"Omura","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Costa, C.A.D., Manaa, W.E., Duplan, E., and Checler, F. (2020). The Endoplasmic Reticulum Stress\/Unfolded Protein Response and Their Contributions to Parkinson\u2019s Disease Physiopathology. Cells, 9.","DOI":"10.3390\/cells9112495"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"104756","DOI":"10.1016\/j.neuint.2020.104756","article-title":"Mitophagy in Parkinson\u2019s disease: From pathogenesis to treatment target","volume":"138","author":"Dernie","year":"2020","journal-title":"Neurochem. Int."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Liu, J., Liu, W., Li, R., and Yang, H. (2019). Mitophagy in Parkinson\u2019s Disease: From Pathogenesis to Treatment. Cells, 8.","DOI":"10.3390\/cells8070712"},{"key":"ref_86","first-page":"a009357","article-title":"The role of autophagy in Parkinson\u2019s disease","volume":"2","author":"Mao","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","article-title":"Autophagy in Parkinson\u2019s Disease","volume":"432","author":"Hou","year":"2020","journal-title":"J. Mol. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.2174\/0929867325666180226094351","article-title":"Role of Autophagy in Parkinson\u2019s Disease","volume":"26","author":"Cerri","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial Dysfunction in Parkinson\u2019s Disease: New Mechanistic Insights and Therapeutic Perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/mds.25462","article-title":"Lysosomal impairment in Parkinson\u2019s disease","volume":"28","author":"Dehay","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tins.2018.11.001","article-title":"Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson\u2019s Disease","volume":"42","author":"Nguyen","year":"2019","journal-title":"Trends Neurosci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/brain\/awy147","article-title":"Is Parkinson\u2019s disease a lysosomal disorder?","volume":"141","author":"Klein","year":"2018","journal-title":"Brain"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"50980","DOI":"10.1074\/jbc.M207825200","article-title":"Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson\u2019s disease","volume":"277","author":"Paitel","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"a009365","DOI":"10.1101\/cshperspect.a009365","article-title":"Programmed cell death in Parkinson\u2019s disease","volume":"2","author":"Venderova","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","article-title":"Understanding Dopaminergic Cell Death Pathways in Parkinson Disease","volume":"90","author":"Michel","year":"2016","journal-title":"Neuron"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/416507a","article-title":"Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases","volume":"416","author":"Bucciantini","year":"2002","journal-title":"Nature"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","article-title":"Impairment of the ubiquitin-proteasome system by protein aggregation","volume":"292","author":"Bence","year":"2001","journal-title":"Science"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0925-4439(00)00039-9","article-title":"Role of the Proteasome in Alzheimer\u2019s disease","volume":"1502","author":"Checler","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1089\/ars.2016.6802","article-title":"The Proteasome and Oxidative Stress in Alzheimer\u2019s Disease","volume":"25","author":"Pomatto","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1073\/pnas.84.9.3033","article-title":"Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer\u2019s disease brains","volume":"84","author":"Perry","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1523\/JNEUROSCI.5078-05.2006","article-title":"Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system","volume":"26","author":"Almeida","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1074\/jbc.272.1.58","article-title":"Binding of amyloid b protein to the 20S proteasome","volume":"272","author":"Gregori","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0014-4886(02)00060-2","article-title":"Relationship between b-amyloid degradation and the 26S proteasome in neural cells","volume":"180","author":"Pasquini","year":"2003","journal-title":"Exp. Neurol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","article-title":"Altered proteasomal function in sporadic Parkinson\u2019s disease","volume":"179","author":"McNaught","year":"2003","journal-title":"Exp. Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41419-021-03441-0","article-title":"Expanding the role of proteasome homeostasis in Parkinson\u2019s disease: Beyond protein breakdown","volume":"12","author":"Bi","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.0b013e3181cbb89a","article-title":"Is there a link between cancer and Alzheimer disease?","volume":"74","author":"Bennett","year":"2010","journal-title":"Neurology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1074\/jbc.M513903200","article-title":"6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation","volume":"281","author":"Dunys","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/77060","article-title":"Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase","volume":"25","author":"Shimura","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"19630","DOI":"10.1074\/jbc.M110.209338","article-title":"Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane","volume":"286","author":"Yoshii","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s13238-015-0230-9","article-title":"Parkin promotes proteasomal degradation of p62: Implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson\u2019s disease","volume":"7","author":"Song","year":"2016","journal-title":"Protein Cell"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0026-0495(00)80077-3","article-title":"What is oxidative stress?","volume":"49","author":"Betteridge","year":"2000","journal-title":"Metab. Clin. Exp."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative Stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archneur.56.12.1449","article-title":"The role of oxidative stress in Alzheimer disease","volume":"56","author":"Markesbery","year":"1999","journal-title":"Arch. Neurol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cam.3.1.7402","article-title":"Oxidative stress in Alzheimer disease","volume":"3","author":"Gella","year":"2009","journal-title":"Cell Adhes. Migr."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1385\/JMN:11:2:151","article-title":"The expression of key oxidative stress-handling genes in different brain regions in Alzheimer\u2019s disease","volume":"11","author":"Aksenov","year":"1998","journal-title":"J. Mol. Neurosci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1038\/s41598-018-29770-3","article-title":"Evidence supporting oxidative stress in a moderately affected area of the brain in Alzheimer\u2019s disease","volume":"8","author":"Youssef","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinson\u2019s Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson\u2019s disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front. Neuroanat."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fnmol.2018.00236","article-title":"Oxidative Stress in Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"11","author":"Wei","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"a006072","DOI":"10.1101\/cshperspect.a006072","article-title":"Cell Signaling and Stress Responses","volume":"8","author":"Hotamisligil","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ceb.2018.04.004","article-title":"Mechanistic insights into ER-associated protein degradation","volume":"53","author":"Wu","year":"2018","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1083\/jcb.201906047","article-title":"Protein quality control in the secretory pathway","volume":"218","author":"Sun","year":"2019","journal-title":"J. Cell Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molcel.2017.05.031","article-title":"The UPR(ER): Sensor and Coordinator of Organismal Homeostasis","volume":"66","author":"Frakes","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","article-title":"Mechanisms, regulation and functions of the unfolded protein response","volume":"21","author":"Hetz","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrneurol.2017.99","article-title":"ER stress and the unfolded protein response in neurodegeneration","volume":"13","author":"Hetz","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1007\/s12035-018-1334-z","article-title":"Cellular Proteostasis in Neurodegeneration","volume":"56","author":"Kurtishi","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Ghemrawi, R., and Khair, M. (2020). Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176127"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00401-005-1038-0","article-title":"The unfolded protein response is activated in Alzheimer\u2019s disease","volume":"110","author":"Hoozemans","year":"2005","journal-title":"Acta Neuropathol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.ajpath.2014.03.014","article-title":"Endoplasmic reticulum stress mediates amyloid beta neurotoxicity via mitochondrial cholesterol trafficking","volume":"184","author":"Fernandez","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nn.3486","article-title":"Suppression of eIF2alpha kinases alleviates Alzheimer\u2019s disease-related plasticity and memory deficits","volume":"16","author":"Ma","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"180024","DOI":"10.1098\/rsob.180024","article-title":"Critical review: Involvement of endoplasmic reticulum stress in the aetiology of Alzheimer\u2019s disease","volume":"8","author":"Hashimoto","year":"2018","journal-title":"Open Biol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainresbull.2020.09.022","article-title":"Involvement of endoplasmic reticulum stress in amyloid beta (1-42)-induced Alzheimer\u2019s like neuropathological process in rat brain","volume":"165","author":"Goswami","year":"2020","journal-title":"Brain Res. Bull."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2353\/ajpath.2009.080480","article-title":"The E693Delta mutation in amyloid precursor protein increases intracellular accumulation of amyloid beta oligomers and causes endoplasmic reticulum stress-induced apoptosis in cultured cells","volume":"174","author":"Nishitsuji","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/acel.12054","article-title":"Ca(2+) -dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid beta-treated astrocytes and in a model of Alzheimer\u2019s disease","volume":"12","author":"Alberdi","year":"2013","journal-title":"Aging Cell"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s11064-012-0780-7","article-title":"Differential activation of the ER stress factor XBP1 by oligomeric assemblies","volume":"37","author":"Zhang","year":"2012","journal-title":"Neurochem. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.stem.2013.01.009","article-title":"Modeling Alzheimer\u2019s disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness","volume":"12","author":"Kondo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.1523\/JNEUROSCI.5397-12.2013","article-title":"Tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation","volume":"33","author":"Abisambra","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.toxlet.2020.01.019","article-title":"Endoplasmic reticulum stress, an important factor in the development of Parkinson\u2019s disease","volume":"324","author":"Mou","year":"2020","journal-title":"Toxicol Lett"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.cdd.4401778","article-title":"ER stress and neurodegenerative diseases","volume":"13","author":"Lindholm","year":"2006","journal-title":"Cell Death Differ."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.3233\/JPD-212673","article-title":"Endoplasmic Reticulum Stress Regulators: New Drug Targets for Parkinson\u2019s Disease","volume":"11","author":"Kovaleva","year":"2021","journal-title":"J. Parkinson\u2019s Dis."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1471-4159.2010.07143.x","article-title":"Induction of the unfolded protein response by alpha-synuclein in experimental models of Parkinson\u2019s disease","volume":"116","author":"Bellucci","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"23179","DOI":"10.1074\/jbc.M802223200","article-title":"Serine 129 Phosphorylation of {alpha}-Synuclein Induces Unfolded Protein Response-mediated Cell Death","volume":"283","author":"Sugeno","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/mt.2012.28","article-title":"Glucose regulated protein 78 diminishes alpha-synuclein neurotoxicity in a rat model of Parkinson disease","volume":"20","author":"Gorbatyuk","year":"2012","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/cdd.2010.142","article-title":"Parkin is transcriptionally regulated by ATF4: Evidence for an interconnection between mitochondrial stress and ER stress","volume":"18","author":"Bouman","year":"2011","journal-title":"Cell Death Differ."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"35661","DOI":"10.1074\/jbc.C000447200","article-title":"Parkin suppresses unfolded protein stress-induced cell deth through its E3 ubiquitin-protein ligase activity","volume":"275","author":"Imai","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0092-8674(01)00407-X","article-title":"An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin","volume":"105","author":"Imai","year":"2001","journal-title":"Cell"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0092-8674(01)00611-0","article-title":"XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor","volume":"107","author":"Yoshida","year":"2001","journal-title":"Cell"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1080\/15548627.2021.1917129","article-title":"Transcription- and phosphorylation-dependent control of a functional interplay between XBP1s and PINK1 governs mitophagy and potentially impacts Parkinson disease pathophysiology","volume":"17","author":"Duplan","year":"2021","journal-title":"Autophagy"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Yuan, Y., Cao, P., Smith, M.A., Kramp, K., Huang, Y., Hisamoto, N., Matsumoto, K., Hatzoglou, M., Jin, H., and Feng, Z. (2011). Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022354"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: Recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"113321","DOI":"10.1016\/j.expneurol.2020.113321","article-title":"Mitochondria in Alzheimer\u2019s disease and their potential role in Alzheimer\u2019s proteostasis","volume":"330","author":"Weidling","year":"2020","journal-title":"Exp. Neurol."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Bell, S.M., Barnes, K., De Marco, M., Shaw, P.J., Ferraiuolo, L., Blackburn, D.J., Venneri, A., and Mortiboys, H. (2021). Mitochondrial Dysfunction in Alzheimer\u2019s Disease: A Biomarker of the Future?. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010063"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tins.2020.10.004","article-title":"Mitochondria and Calcium in Alzheimer\u2019s Disease: From Cell Signaling to Neuronal Cell Death","volume":"44","author":"Bacskai","year":"2021","journal-title":"Trends Neurosci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3233\/JAD-170585","article-title":"Mitochondria and Mitochondrial Cascades in Alzheimer\u2019s Disease","volume":"62","author":"Swerdlow","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.4238\/2015.June.29.15","article-title":"Potential hippocampal genes and pathways involved in Alzheimer\u2019s disease: A bioinformatic analysis","volume":"14","author":"Zhang","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jalz.2016.09.003","article-title":"Nuclear but not mitochondrial-encoded oxidative phosphorylation genes are altered in aging, mild cognitive impairment, and Alzheimer\u2019s disease","volume":"13","author":"Mastroeni","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gde.2016.04.006","article-title":"Mitochondria-associated ER membranes and Alzheimer disease","volume":"38","author":"Schon","year":"2016","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Eysert, F., Kinoshita, P.F., Mary, A., Vaillant-Beuchot, L., Checler, F., and Chami, M. (2020). Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249521"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Chen, C., Turnbull, D.M., and Reeve, A.K. (2019). Mitochondrial Dysfunction in Parkinson\u2019s Disease-Cause or Consequence?. Biology, 8.","DOI":"10.3390\/biology8020038"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/DDDT.S130514","article-title":"Proteinopathy, oxidative stress and mitochondrial dysfunction: Cross talk in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"11","author":"Ganguly","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.freeradbiomed.2009.11.026","article-title":"Oxidative damage in Parkinson disease: Measurement using accurate biomarkers","volume":"48","author":"Seet","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1523\/JNEUROSCI.0212-07.2007","article-title":"Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone","volume":"27","author":"Yadava","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.molcel.2009.02.013","article-title":"PINK1-associated Parkinson\u2019s disease is caused by neuronal vulnerability to calcium-induced cell death","volume":"33","author":"Gandhi","year":"2009","journal-title":"Mol. Cell"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"615461","DOI":"10.3389\/fcell.2020.615461","article-title":"Targeting Mitochondrial Impairment in Parkinson\u2019s Disease: Challenges and Opportunities","volume":"8","author":"Prasuhn","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1471-4159.2012.07734.x","article-title":"Parkinson\u2019s disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction","volume":"121","author":"Wang","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/hmg\/dds003","article-title":"LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1","volume":"21","author":"Wang","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.stem.2016.08.002","article-title":"Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson\u2019s Disease","volume":"19","author":"Hsieh","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","article-title":"alpha-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease","volume":"9","author":"Ludtmann","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","article-title":"PINK1 and Parkin mitochondrial quality control: A source of regional vulnerability in Parkinson\u2019s disease","volume":"15","author":"Ge","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ceb.2015.01.002","article-title":"PINK1\/Parkin-mediated mitophagy in mammalian cells","volume":"33","author":"Eiyama","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tcb.2016.05.008","article-title":"Deciphering the Molecular Signals of PINK1\/Parkin Mitophagy","volume":"26","author":"Nguyen","year":"2016","journal-title":"Trends Cell Biol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","article-title":"Mitophagy and Alzheimer\u2019s Disease: Cellular and Molecular Mechanisms","volume":"40","author":"Kerr","year":"2017","journal-title":"Trends Neurosci."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Cai, Q., and Jeong, Y.Y. (2020). Mitophagy in Alzheimer\u2019s Disease and Other Age-Related Neurodegenerative Diseases. Cells, 9.","DOI":"10.3390\/cells9010150"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"101191","DOI":"10.1016\/j.arr.2020.101191","article-title":"Defective mitophagy in Alzheimer\u2019s disease","volume":"64","author":"Pradeepkiran","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","article-title":"Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease","volume":"22","author":"Fang","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Reddy, P.H., and Oliver, D.M. (2019). Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer\u2019s Disease. Cells, 8.","DOI":"10.3390\/cells8050488"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: Intracellular Ab and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-021-00796-3","article-title":"Accumulation of APP-CTF induces mitophagy dysfunction in the iNSCs model of Alzheimer\u2019s disease","volume":"8","author":"Lee","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","article-title":"Mitochondrial Dysfunction and Mitophagy in Parkinson\u2019s Disease: From Mechanism to Therapy","volume":"46","author":"Malpartida","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1093\/hmg\/ddq419","article-title":"Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1\/parkin-dependent manner upon induction of mitophagy","volume":"19","author":"Gegg","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1471-4159.2011.07318.x","article-title":"Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1","volume":"118","author":"Glauser","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"e48686","DOI":"10.15252\/embr.201948686","article-title":"PINK1 phosphorylates Drp1(S616) to regulate mitophagy-independent mitochondrial dynamics","volume":"21","author":"Han","year":"2020","journal-title":"EMBO Rep."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.embor.7401062","article-title":"Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death","volume":"8","author":"Cribbs","year":"2007","journal-title":"EMBO Rep."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"13843","DOI":"10.1074\/jbc.M808515200","article-title":"Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission","volume":"284","author":"Dagda","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1111\/j.1742-4658.2009.07201.x","article-title":"Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling","volume":"276","author":"Sandebring","year":"2009","journal-title":"FEBS J."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.biopsych.2017.04.011","article-title":"beta-Amyloid Precursor Protein Intracellular Domain Controls Mitochondrial Function by Modulating Phosphatase and Tensin Homolog-Induced Kinase 1 Transcription in Cells and in Alzheimer Mice Models","volume":"83","author":"Goiran","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrm.2016.149","article-title":"Necroptosis in development, inflammation and disease","volume":"18","author":"Weinlich","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_191","unstructured":"Stoker, T.B., and Greenland, J.C. (2018). Apoptosis and its Role in Parkinson\u2019s Disease. Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects, Exon Publications."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"506","DOI":"10.14336\/AD.2016.1120","article-title":"P53 Dysfunction in Neurodegenerative Diseases-The Cause or Effect of Pathological Changes?","volume":"8","author":"Szybinska","year":"2017","journal-title":"Aging Dis."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cellsig.2010.10.020","article-title":"Apoptosis in Parkinson\u2019s disease: Is p53 the missing link between genetic and sporadic Parkinsonism?","volume":"23","author":"Checler","year":"2011","journal-title":"Cell Signal"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10495-006-6316-3","article-title":"Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson\u2019s disease","volume":"11","author":"Nair","year":"2006","journal-title":"Apoptosis"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2006.12.003","article-title":"p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain","volume":"414","author":"Mogi","year":"2007","journal-title":"Neurosci. Lett."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1126\/science.285.5434.1733","article-title":"A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy","volume":"285","author":"Komarov","year":"1999","journal-title":"Science"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11064-005-6877-5","article-title":"Puma and p53 play required roles in death-evoked in a cellular model of Parkinson disease","volume":"30","author":"Biswas","year":"2005","journal-title":"Neurochem. Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.18632\/oncotarget.14385","article-title":"\u03b1-synuclein and p53 functional interplay in physiopathological contexts","volume":"8","author":"Duplan","year":"2017","journal-title":"Oncotarget"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/jnc.13706","article-title":"Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson\u2019s disease model","volume":"138","author":"Qi","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"24065","DOI":"10.1074\/jbc.M002413200","article-title":"Wild-type but not Parkinson\u2019s disease-related Ala53Thr-a-synuclein protect neuronal cells from apoptotic stimuli","volume":"275","author":"Ancolio","year":"2000","journal-title":"J. Biol. Chem"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"37330","DOI":"10.1074\/jbc.M306083200","article-title":"Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: Cross-talk with alpha-synuclein and implication for Parkinson\u2019s disease","volume":"278","author":"Masliah","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13024-016-0079-2","article-title":"Direct alpha-synuclein promoter transactivation by the tumor suppressor p53","volume":"11","author":"Duplan","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"20702","DOI":"10.18632\/aging.103998","article-title":"Stress-induced p53 drives BAG5 cochaperone expression to control alpha-synuclein aggregation in Parkinson\u2019s disease","volume":"12","author":"Chen","year":"2020","journal-title":"Aging"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ncb1981","article-title":"Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson\u2019s disease","volume":"11","author":"Sunyach","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1326-8-29","article-title":"S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson\u2019s disease","volume":"8","author":"Sunico","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"10810","DOI":"10.1073\/pnas.0404161101","article-title":"Nitrosative stress linked to sporadic Parkinson\u2019s disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity","volume":"101","author":"Yao","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/onc.2013.124","article-title":"Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity","volume":"33","author":"Viotti","year":"2014","journal-title":"Oncogene"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"16259","DOI":"10.1073\/pnas.1113884108","article-title":"Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1093\/hmg\/ddt068","article-title":"The Parkinson disease-related protein DJ-1 counteracts mitochondrial impairment induced by the tumour suppressor protein p53 by enhancing endoplasmic reticulum-mitochondria tethering","volume":"22","author":"Ottolini","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_210","first-page":"2124","article-title":"ER-stress-associated functional link between Parkin and DJ-1 via a transcriptional cascade involving the tumor suppressor p53 and the spliced X-box binding protein XBP-1","volume":"126","author":"Duplan","year":"2013","journal-title":"J. Cell Sci."},{"key":"ref_211","first-page":"873","article-title":"Nuclear p53-mediated repression of autophagy involves PINK1 transcriptional down-regulation","volume":"25","author":"Goiran","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.molcel.2017.09.022","article-title":"Mitophagy Controls the Activities of Tumor Suppressor p53 to Regulate Hepatic Cancer Stem Cells","volume":"68","author":"Liu","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/156720506778249470","article-title":"Apoptosis in Alzheimer disease: A mathematical improbability","volume":"3","author":"Zhu","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s11064-014-1454-4","article-title":"Apoptosis in Alzheimer\u2019s disease: An understanding of the physiology, pathology and therapeutic avenues","volume":"39","author":"Obulesu","year":"2014","journal-title":"Neurochem. Res."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13195-020-00732-0","article-title":"The pleiotropic role of p53 in functional\/dysfunctional neurons: Focus on pathogenesis and diagnosis of Alzheimer\u2019s disease","volume":"12","author":"Abate","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1006\/bbrc.1997.6301","article-title":"Changes of p53 in the brains patients with Alzheimer disease","volume":"232","author":"Kitamura","year":"1997","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.mp.4002060","article-title":"Conformationally altered p53: A novel Alzheimer\u2019s disease marker?","volume":"13","author":"Lanni","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41392-020-0196-9","article-title":"Regulating tumor suppressor genes: Post-translational modifications","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1096\/fj.04-2637fje","article-title":"Intracellular Abeta42 activates p53 promoter: A pathway to neurodegeneration in Alzheimer\u2019s disease","volume":"19","author":"Ohyagi","year":"2005","journal-title":"FASEB J."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000283483","article-title":"p53 Is Regulated by and Regulates Members of the gamma-Secretase Complex","volume":"7","author":"Checler","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1523\/JNEUROSCI.0651-06.2006","article-title":"Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer\u2019s disease","volume":"26","author":"Sunyach","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"12064","DOI":"10.1074\/jbc.M212379200","article-title":"The C-terminal fragment of presenilin 2 triggers p53-mediated staurosporine-induced apoptosis, a function independent of the presenilinase-derived N-terminal counterpart","volume":"278","author":"Mattson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1073\/pnas.062059899","article-title":"Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons","volume":"99","author":"Paitel","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature01506","article-title":"The role of presenilin cofactors in the g-secretase complex","volume":"422","author":"Takasugi","year":"2003","journal-title":"Nature"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncb960","article-title":"Reconstitution of g-secretase activity","volume":"5","author":"Edbauer","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"10516","DOI":"10.1074\/jbc.M611572200","article-title":"p53-dependent Aph-1 and Pen-2 anti-apoptotic phenotype requires the integrity of the gamma-secretase complex but is independent of its activity","volume":"282","author":"Dunys","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1471-4159.2009.05952.x","article-title":"p53-dependent control of cell death by nicastrin: Lack of requirement for presenilin-dependent gamma-secretase complex","volume":"109","author":"Dunys","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1042\/BJ20081793","article-title":"The tumor suppressor p53 regulates the expression of the beta-amyloid precursor protein","volume":"418","author":"Cuesta","year":"2008","journal-title":"Biochem. J."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1471-4159.2011.07475.x","article-title":"The physiology of the beta-amyloid precursor protein intracellular domain AICD","volume":"120","author":"Checler","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/74656","article-title":"A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor","volume":"6","author":"Lu","year":"2000","journal-title":"Nat. Med."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbrc.2006.09.162","article-title":"The intracellular domain of the amyloid precursor protein (AICD) enhances the p53-mediated apoptosis","volume":"351","author":"Ozaki","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.neurobiolaging.2015.06.021","article-title":"The amyloid precursor protein (APP) intracellular domain regulates translation of p44, a short isoform of p53, through an IRES-dependent mechanism","volume":"36","author":"Li","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1046\/j.1471-4159.2001.00513.x","article-title":"The caspase-derived C-terminal fragment of betaAPP induces caspase-independent toxicity and triggers selective increase of Abeta42 in mammalian cells","volume":"78","author":"Mercken","year":"2001","journal-title":"J. Neurochem."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2009.08.042","article-title":"Mechanism of cytotoxicity mediated by the C31 fragment of the Amyloid Precursor Protein","volume":"388","author":"Park","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fpsyt.2010.00015","article-title":"The Relationship between Parkin and Protein Aggregation in Neurodegenerative Diseases","volume":"1","author":"Khandelwal","year":"2010","journal-title":"Front. Psychiatry"},{"key":"ref_236","first-page":"248","article-title":"Parkin Regulation and Neurodegenerative Disorders","volume":"7","author":"Zhang","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.nbd.2009.08.009","article-title":"Parkinson\u2019s disease-associated parkin colocalizes with Alzheimer\u2019s disease and multiple sclerosis brain lesions","volume":"36","author":"Witte","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"101971","DOI":"10.1016\/j.npep.2019.101971","article-title":"Abeta, Tau, and alpha-Synuclein aggregation and integrated role of PARK2 in the regulation and clearance of toxic peptides","volume":"78","author":"Kumar","year":"2019","journal-title":"Neuropeptides"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"674071","DOI":"10.3389\/fnagi.2021.674071","article-title":"Insights Into Parkin-Mediated Mitophagy in Alzheimer\u2019s Disease: A Systematic Review","volume":"13","author":"Goudarzi","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/hmg\/ddv056","article-title":"Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer\u2019s disease patient brains","volume":"24","author":"Ye","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/gerona\/glab142","article-title":"Rapamycin Activates Mitophagy and Alleviates Cognitive and Synaptic Plasticity Deficits in a Mouse Model of Alzheimer\u2019s Disease","volume":"76","author":"Wang","year":"2021","journal-title":"J. Gerontol. Ser. A"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/hmg\/ddv616","article-title":"PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer\u2019s disease","volume":"25","author":"Gargini","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"117322","DOI":"10.1016\/j.lfs.2020.117322","article-title":"Parkin overexpression attenuates Abeta-induced mitochondrial dysfunction in HEK293 cells by restoring impaired mitophagy","volume":"244","author":"Wang","year":"2020","journal-title":"Life Sci."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/hmg\/ddr091","article-title":"Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated Abeta in AD models","volume":"20","author":"Khandelwal","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuroscience.2012.08.057","article-title":"Parkin prevents cortical atrophy and Abeta-induced alterations of brain metabolism: (1)(3)C NMR and magnetic resonance imaging studies in AD models","volume":"225","author":"Algarzae","year":"2012","journal-title":"Neuroscience"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jnr.22178","article-title":"Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function","volume":"88","author":"Rosen","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/hmg\/ddt501","article-title":"Parkin overexpression ameliorates hippocampal long-term potentiation and beta-amyloid load in an Alzheimer\u2019s disease mouse model","volume":"23","author":"Hong","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.1074\/jbc.M512649200","article-title":"Parkin protects against mitochondrial toxins and beta-amyloid accumulation in skeletal muscle cells","volume":"281","author":"Rosen","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1042\/BCJ20200488","article-title":"Amyloid-beta oligomers induce Parkin-mediated mitophagy by reducing Miro1","volume":"477","author":"Kam","year":"2020","journal-title":"Biochem J"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JAD-2012-120406","article-title":"Parkin null cortical neuronal\/glial cultures are resistant to amyloid-beta1-42 toxicity: A role for autophagy?","volume":"32","author":"Solano","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s11011-020-00587-2","article-title":"beta-Asarone improves learning and memory in Abeta1-42-induced Alzheimer\u2019s disease rats by regulating PINK1-Parkin-mediated mitophagy","volume":"35","author":"Han","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3389\/fphar.2019.01529","article-title":"beta-Asarone Inhibits Amyloid-beta by Promoting Autophagy in a Cell Model of Alzheimer\u2019s Disease","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"114859","DOI":"10.1016\/j.jep.2021.114859","article-title":"Panax notoginseng saponins protect PC12 cells against Abeta induced injury via promoting parkin-mediated mitophagy","volume":"285","author":"Jiang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00109-013-1112-3","article-title":"Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance","volume":"92","author":"Lonskaya","year":"2014","journal-title":"J. Mol. Med."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"17356","DOI":"10.18632\/oncotarget.7861","article-title":"Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial Parkin","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"e99360","DOI":"10.15252\/embj.201899360","article-title":"Disease-associated tau impairs mitophagy by inhibiting Parkin translocation to mitochondria","volume":"38","author":"Cummins","year":"2019","journal-title":"EMBO J."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12031-008-9099-x","article-title":"Parkin attenuates wild-type tau modification in the presence of beta-amyloid and alpha-synuclein","volume":"37","author":"Moussa","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/hmg\/9.2.195","article-title":"Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse","volume":"9","author":"Baxter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbrc.2021.05.016","article-title":"Parkin is downregulated among autophagy-related proteins prior to hyperphosphorylation of Tau in TS65DN mice","volume":"561","author":"Henrique","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JAD-2008-13206","article-title":"Park2-null\/tau transgenic mice reveal a functional relationship between parkin and tau","volume":"13","author":"Guerrero","year":"2008","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/hmg\/ddl129","article-title":"Suppression of Parkin enhances nigrostriatal and motor neuron lesion in mice over-expressing human-mutated tau protein","volume":"15","author":"Menendez","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/hmg\/ddn210","article-title":"Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice","volume":"17","author":"Gomez","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-008-0470-3","article-title":"Hyperphosphorylated tau aggregates in the cortex and hippocampus of transgenic mice with mutant human FTDP-17 Tau and lacking the PARK2 gene","volume":"117","author":"Guerrero","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13195-018-0394-7","article-title":"Alzheimer\u2019s disease master regulators analysis: Search for potential molecular targets and drug repositioning candidates","volume":"10","author":"Vargas","year":"2018","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/jmcb\/mjt003","article-title":"Parkin differently regulates presenilin-1 and presenilin-2 functions by direct control of their promoter transcription","volume":"5","author":"Duplan","year":"2013","journal-title":"J. Mol. Cell Biol."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"16243","DOI":"10.1523\/JNEUROSCI.2775-12.2012","article-title":"The beta-secretase-derived C-terminal fragment of betaAPP, C99, but not Abeta, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus","volume":"32","author":"Lauritzen","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jalz.2019.09.002","article-title":"C99 selectively accumulates in vulnerable neurons in Alzheimer\u2019s disease","volume":"16","author":"Pulina","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40035-019-0176-6","article-title":"Targeting gamma-secretase triggers the selective enrichment of oligomeric APP-CTFs in brain extracellular vesicles from Alzheimer cell and mouse models","volume":"8","author":"Lauritzen","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.7150\/thno.57549","article-title":"Therapeutic potential of parkin as a tumor suppressor via transcriptional control of cyclins in glioblastoma cell and animal models","volume":"11","author":"Rouland","year":"2021","journal-title":"Theranostics"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuron.2005.04.008","article-title":"Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP","volume":"46","author":"Petit","year":"2005","journal-title":"Neuron"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"18367","DOI":"10.1073\/pnas.0907652106","article-title":"Alzheimer\u2019s disease-like pathological features in transgenic mice expressing the APP intracellular domain","volume":"106","author":"Ghosal","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2119\/molmed.2016.00229","article-title":"The transcription factor XBP1 in memory and cognition: Implications in Alzheimer disease","volume":"22","author":"Cisse","year":"2017","journal-title":"Mol. Med."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/mp.2016.152","article-title":"The transcription factor XBP1s restores hippocampal synaptic plasticity and memory by control of the Kalirin-7 pathway in Alzheimer model","volume":"22","author":"Cisse","year":"2017","journal-title":"Mol. Psychiatry"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/4\/559\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:50:55Z","timestamp":1760136655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/4\/559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":273,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["biom12040559"],"URL":"https:\/\/doi.org\/10.3390\/biom12040559","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,9]]}}}